MTNBNYSEPharmaceutical PreparationsFiscal year ends December 31
Matinas BioPharma Holdings, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$1.66−0.71 (-29.96%)
Close on Oct 19, 2026
- Market cap
- $10.63M
- P/E (TTM)
- –
- Dividend yield
- –
Ownership
Who owns Matinas BioPharma's shares
Held by institutions
–
Shares held, 13F filers
Institutional holders
–
Net institutional buying
–
Insider trades, 12 months
0 buys · 0 sales
Open-market trades only
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Lazar David E. | 545,000 | 9.81% | 13G (passive) | Aug 15, 2025 |
| Stern Adam K | 2,972,524 | 9.99% | 13D (active) amendment | Jun 10, 2026 |
| Robert J. Eide | 16,895,712 | 9.99% | 13D (active) amendment | Apr 8, 2025 |
| Hezbay Holdings LLC | 1,306,488 | 9.54% | 13G (passive) | Jul 13, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Jerome D. Jabbour | President and CEO, Director | 810,011 | 5.51% | May 2, 2025 |
| An Evelyn D | Director | – | – | May 2, 2025 |
| Robin L. Smith | Director | – | – | May 2, 2025 |
| Keith Murphy | Director | – | – | May 2, 2025 |
| Edward Neugeboren | Director | – | – | May 2, 2025 |
| Partners LLC Sanitam | 10% owner | – | – | Aug 13, 2026 |
| Adam K. Stern | 10% owner | 1,231,445 | 8.38% | Aug 13, 2026 |
| & Partners LLC Pembroke | 10% owner | – | – | Apr 10, 2025 |
| Robert J. Eide | 10% owner | 3,000 | 0.02% | Apr 10, 2025 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Adam K. Stern 10% owner | Jul 10, 2026 | Option exercise | +344,710 | $0.35 | $120.65K | 416,900 |
| Adam K. Stern 10% owner | Jul 10, 2026 | Option exercise | +630,335 | $0.35 | $220.62K | 743,785 |
| Adam K. Stern 10% owner | Oct 31, 2025 | Option exercise | +92,100 | $0.64 | $58.94K | 113,450 |
| Herbert J. Conrad Director | Jun 22, 2022 | Gift | +1,358,122 | – | – | 4,694,566 |
| Herbert J. Conrad Director | Jun 22, 2022 | Gift | −1,358,122 | – | – | 0 |
| Matthew Wikler Director | Dec 31, 2021 | Award | +7,859 | – | – | 290,472 |
| Matthew Wikler Director | Sep 30, 2021 | Award | +6,106 | – | – | 282,613 |
| Raphael J. Mannino Chief Scientific Officer | Sep 3, 2021 | Other | +462,150 | – | – | 1,919,715 |
| Herbert J. Conrad Director | Aug 4, 2021 | Gift | −494,622 | – | – | 0 |
| Herbert J. Conrad Director | Aug 4, 2021 | Gift | +494,622 | – | – | 3,336,444 |
| Herbert J. Conrad Director | Jul 7, 2021 | Gift | −1,280,917 | – | – | 1,358,122 |
| Herbert J. Conrad Director | Jul 7, 2021 | Gift | +1,280,917 | – | – | 2,841,822 |
| Matthew Wikler Director | Jun 30, 2021 | Award | +10,244 | – | – | 276,507 |
| Jerome D. Jabbour President and CEO, Director | Jun 19, 2021 | Other | +6,000 | – | – | 810,011 |
| Jerome D. Jabbour President and CEO, Director | Jun 19, 2021 | Conversion | +30,000 | – | – | 840,011 |
| Eric J. Ende Director | Jun 19, 2021 | Conversion | +24,000 | – | – | 144,092 |
| Eric J. Ende Director | Jun 19, 2021 | Other | +4,800 | – | – | 120,092 |
| Matthew Wikler Director | Jun 19, 2021 | Other | +2,400 | – | – | 254,263 |
| Matthew Wikler Director | Jun 19, 2021 | Conversion | +12,000 | – | – | 266,263 |
| Raphael J. Mannino Chief Scientific Officer | Jun 19, 2021 | Conversion | +20,000 | – | – | 1,457,565 |
| Raphael J. Mannino Chief Scientific Officer | Jun 19, 2021 | Other | +8,000 | – | – | 1,437,565 |
| James S. Scibetta Director | Jun 19, 2021 | Other | +4,800 | – | – | 625,958 |
| James S. Scibetta Director | Jun 19, 2021 | Conversion | +24,000 | – | – | 649,958 |
| Herbert J. Conrad Director | Jun 19, 2021 | Conversion | +200,000 | – | – | 1,560,905 |
| Herbert J. Conrad Director | Jun 19, 2021 | Other | +40,000 | – | – | 1,360,905 |
| Herbert J. Conrad Director | May 20, 2021 | Gift | +1,145,905 | – | – | 1,320,905 |
| Herbert J. Conrad Director | May 20, 2021 | Gift | −1,145,905 | – | – | 0 |
| Matthew Wikler Director | Mar 31, 2021 | Award | +7,560 | – | – | 251,863 |
| Herbert J. Conrad Director | Jan 13, 2021 | Gift | −50,000 | – | – | 494,622 |
| Herbert J. Conrad Director | Jan 13, 2021 | Gift | +50,000 | – | – | 175,000 |
| Matthew Wikler Director | Dec 31, 2020 | Award | +11,673 | – | – | 244,303 |
| Matthew Wikler Director | Sep 30, 2020 | Award | +20,725 | – | – | 232,630 |
| Adam K. Stern Director | Aug 21, 2020 | Buy | +20,000 | $0.83 | $16.60K | 3,301,983 |
| Matthew Wikler Director | Jun 30, 2020 | Award | +20,537 | – | – | 211,905 |
| Raphael J. Mannino Chief Scientific Officer | Jun 23, 2020 | Other | +3,000 | – | – | 1,429,565 |
| Herbert J. Conrad Director | Jun 23, 2020 | Other | +30,000 | – | – | 544,622 |
| Jerome D. Jabbour President and CEO, Director | Jun 23, 2020 | Other | +4,500 | – | – | 804,011 |
| James S. Scibetta Director | Jun 23, 2020 | Other | +3,600 | – | – | 621,158 |
| Matthew Wikler Director | Jun 23, 2020 | Other | +1,800 | – | – | 191,368 |
| Eric J. Ende Director | Jun 23, 2020 | Other | +3,600 | – | – | 115,292 |
| Adam K. Stern Director | Jun 23, 2020 | Other | +25,500 | – | – | 3,281,983 |
| Herbert J. Conrad Director | Jun 4, 2020 | Gift | −2,639,039 | – | – | 125,000 |
| Herbert J. Conrad Director | Jun 4, 2020 | Gift | +2,639,039 | – | – | 2,639,039 |
| Patrick G. Lepore Director | May 14, 2020 | Buy | +100,000 | $0.73 | $73.00K | 400,000 |
| Herbert J. Conrad Director | May 13, 2020 | Gift | +2,639,039 | – | – | 2,764,039 |
| Herbert J. Conrad Director | May 13, 2020 | Gift | −2,639,039 | – | – | 1,145,905 |
| Adam K. Stern Director | Apr 3, 2020 | Option exercise | +278,407 | $0.50 | $139.20K | 1,337,399 |
| Matthew Wikler Director | Mar 31, 2020 | Award | +26,450 | – | – | 189,568 |
| Adam K. Stern Director | Mar 17, 2020 | Buy | +10,000 | $0.65 | $6.50K | 10,000 |
| Jerome D. Jabbour President and CEO, Director | Mar 17, 2020 | Buy | +10,000 | $0.65 | $6.50K | 799,511 |
| Matthew Wikler Director | Dec 31, 2019 | Award | +6,994 | – | – | 163,118 |
| James S. Scibetta Director | Dec 31, 2019 | Award | +8,260 | – | – | 617,558 |
| Herbert J. Conrad Director | Dec 31, 2019 | Award | +10,573 | – | – | 514,622 |
| Keith A. Kucinski Chief Financial Officer | Nov 25, 2019 | Buy | +58,000 | $1.23 | $71.34K | 94,500 |
| Keith A. Kucinski Chief Financial Officer | Nov 22, 2019 | Buy | +36,500 | $1.20 | $43.80K | 36,500 |
| Patrick G. Lepore Director | Nov 15, 2019 | Buy | +100,000 | $1.06 | $106.00K | 300,000 |
| Herbert J. Conrad Director | Sep 30, 2019 | Award | +38,066 | – | – | 504,049 |
| James S. Scibetta Director | Sep 30, 2019 | Award | +29,739 | – | – | 606,898 |
| Matthew Wikler Director | Sep 30, 2019 | Award | +25,179 | – | – | 154,924 |
| Eric J. Ende Director | Aug 20, 2019 | Buy | +20,000 | $0.66 | $13.20K | 109,292 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.